CHNA
Loncar China BioPharma ETFCHNA Fund Description
CHNA tracks a tier-weighted index of companies directly involved in the growth of China’s pharmaceutical and biotech industry.
CHNA Factset Analytics Insight
CHNA targets China’s pharmaceutical and biotech (biopharma) sector. The fund includes pharmaceutical companies, biotech companies, drug manufacturers, diagnostics companies, wholesalers or distributors of biopharma products, and biopharma service providers. It is worth noting that manufacturers of pharmaceutical ingredients are excluded, as the fund focuses on innovation in the sector. CHNA uses a tiered weighting system. Starting from equal weight, all qualified constituents are assigned a weight adjustment based on market cap. Large cap stocks get a 140% adjustment, midcaps 100%, and small-caps 70%. For this exposure, CHNA charge a fee in line with its closest competitors, although still at a price worth consideration.
CHNA CHARTS AND PERFORMANCE
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
3 Years
-
5 Years
-
Max
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
3 Years
-
5 Years
-
Max
-
CHNA Top 10 Countries
CHNA Top 10 Sectors
CHNA Top 10 Holdings [View All]
CHNA Summary Data
CHNA Portfolio Data
CHNA Index Data
CHNA Portfolio Management
CHNA Tax Exposures
CHNA Fund Structure
CHNA Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of CHNA. CHNA is rated a 1 out of 5.
CHNA Tradability
CHNA Sector/Industry Breakdown
CHNA
CHNA TOP 10 HOLDINGS[View All]
CHNA Countries
CHNA
CHNA Regions
CHNA
CHNA Economic Development
CHNA
CHNA Performance Statistics
CHNA BENCHMARK COMPARISON SUMMARY
CHNA
CHNA BENCHMARK COMPARISON MARKET CAP SIZE
CHNA
The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.
ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.
[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.
Data provider:
Terms of Use